spatula, <specify>
douglas bean (australia) pty ltd -
13645 - spatula,
california mugwort injection, solution
nelco laboratories, inc. - artemisia douglasiana pollen (unii: k1301r7883) (artemisia douglasiana pollen - unii:k1301r7883) - artemisia douglasiana pollen 0.05 g in 1 ml - allergenic extracts are indicated for use in diagnostic testing and as part of a treatment regime for allergic disease, as established by allergy history and skin test reactivity. allergenic extracts are indicated for the treatment of allergen specific allergic disease for use as hyposensitization or immunotherapy when avoidance of specific allergens can not be attained. the use of allergenic extracts for therapeutic purpose has been established by well-controlled clinical studies. allergenic extracts may be used as adjunctive therapy along with pharmacotherapy which includes antihistamines, corticosteroids, and cromoglycate, and avoidance measures. allergenic extracts for therapeutic use should be given using only the allergen selection to which the patient is allergic, has a history of exposure and are likely to be exposed to again. allergenic extracts should not be used if the patient has asthma, cardiovascular disease, emphysema, diabetes, bleeding diathesis or pregnancy, unless a specific diagnosis of t
calvasc
douglas pharmaceuticals limited - amlodipine mesilate 12.79mg equivalent to amlodipine 10 mg; ; - tablet - 10 mg - active: amlodipine mesilate 12.79mg equivalent to amlodipine 10 mg excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate
calvasc
douglas pharmaceuticals limited - amlodipine mesilate 6.395mg equivalent to amlodipine 5.0 mg; ; - tablet - 5 mg - active: amlodipine mesilate 6.395mg equivalent to amlodipine 5.0 mg excipient: calcium hydrogen phosphate magnesium stearate microcrystalline cellulose sodium starch glycolate
azamun
douglas pharmaceuticals limited - azathioprine 50mg; - film coated tablet - 50 mg - active: azathioprine 50mg excipient: croscarmellose sodium maize starch mannitol microcrystalline cellulose opadry clear oy-7240 povidone sodium stearyl fumarate - azamun is used as an immunosuppressant anti-metabolite either alone, or more commonly in combination with other agents (usually corticosteroids) and procedures that influence the immune response. the therapeutic effect of azamun may be evident only after weeks or months and can include a steroid-sparing effect, thereby reducing the toxicity associated with high dosage and prolonged use of corticosteroids. azamun, in combination with corticosteroids and/or other immune-suppressive agents and procedures is indicated to enhance survival of organ transplants, such as renal, cardiac and hepatic transplants; and to reduce corticosteroid requirements of renal transplant recipients.
bicalox
douglas pharmaceuticals limited - bicalutamide 50mg; - film coated tablet - 50 mg - active: bicalutamide 50mg excipient: lactose monohydrate magnesium stearate opadry white y-1-7000 povidone sodium starch glycolate - treatment of advanced prostate cancer in combination with gnrh (lhrh) agonist therapy or surgical castration. prevention of disease flare associated with the use of lhrh agonists.
bosvate
douglas pharmaceuticals limited - bisoprolol fumarate 10mg; - tablet - 10 mg - active: bisoprolol fumarate 10mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose sodium starch glycolate - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.
bosvate
douglas pharmaceuticals limited - bisoprolol fumarate 2.5mg; - tablet - 2.5 mg - active: bisoprolol fumarate 2.5mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose sodium starch glycolate - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.
bosvate
douglas pharmaceuticals limited - bisoprolol fumarate 5mg; - tablet - 5 mg - active: bisoprolol fumarate 5mg excipient: colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose sodium starch glycolate - treatment of stable chronic heart failure with reduced systolic left ventricular function in addition to ace inhibitors, and diuretics, and optionally cardiac glycosides.
clopine
douglas pharmaceuticals limited - clozapine 50 mg/ml; ; - oral suspension - 50 mg/ml - active: clozapine 50 mg/ml excipient: glycerol hydrochloric acid monobasic sodium phosphate dihydrate povidone purified water sodium hydroxide sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate sorbitol xanthan gum - the use of clozapine is indicated in the treatment of resistant schizophrenic patients only, i.e. schizophrenic patients who are non-responsive to or intolerant of classical antipsychotics. non-responsiveness is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two marketed antipsychotics prescribed for adequate durations. intolerance is defined as the impossibility of achieving adequate clinical benefit with classical antipsychotic drugs because of severe and untreatable neurological adverse reactions (extrapyramidal side effects or tardive dyskinesia).